Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
17. November 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9151
Articles 1 - 20 / 183006
Early Real-World Outcomes and Safety of Belzutifan in Japanese Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.
Clin Genitourin Cancer
Takeuchi K, Okamoto T, Sekine Y, Shinohara M, Tamaki G, Abe N, Kobayashi S, Fujita N, Sato S, Habuchi T, Hatakeyama S, Numakura K.
PMID: 43039759 [PubMed - as supplied by publisher]
Time to nephrectomy in pathological T stage (pT)1b-2 renal cancer and the decision made at diagnosis.
BJU Int
Luo H, Ye T.
PMID: 43039643 [PubMed - as supplied by publisher]
Prostate Cancer and PSMA PET/CT.
Magn Reson Imaging Clin N Am
Arca B, Sanli Y.
PMID: 43039506 [PubMed - indexed for MEDLINE]
MR Clinics-Nuclear Medicine in Renal, Adrenal, Bladder and Urothelial Malignancies.
Magn Reson Imaging Clin N Am
Romsa J, Sutherland D, Akincioglu C.
PMID: 43039504 [PubMed - indexed for MEDLINE]
Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in Prostate Cancer: Patient Selection, Treatment Workflow, and Emerging Directions.
Magn Reson Imaging Clin N Am
Denizmen Zorba D, Sanli Y.
PMID: 43039498 [PubMed - indexed for MEDLINE]
INTERMITTENT ANDROGEN DEPRIVATION THERAPY PLUS COMPREHENSIVE STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOMETASTATIC HORMONE SENSITIVE PROSTATE CANCER (CROP): MATURE RESULTS OF A PROSPECTIVE TRIAL.
Int J Radiat Oncol Biol Phys
Cheung P, Tseng CL, Chung H, Chu W, Vesprini D, Liu S, Sahgal A, Soliman H, Myrehaug S, Detsky J, Chung P, Helou J, Emmenegger U, Escueta V, Mamedov A, Zhang L, Morton G, Loblaw A.
PMID: 43039250 [PubMed - as supplied by publisher]
Tumor-associated neutrophil heterogeneity in prostate cancer: functional plasticity, phenotypic states, and therapeutic implications.
Transl Oncol
Melchior F, Salcher S, Pircher A, Heidegger I.
PMID: 43038767 [PubMed - as supplied by publisher]
Quality-of-life outcomes of MR-guided ultrahypofractionated SBRT versus CBCT-guided moderately hypofractionated IMRT for localized prostate cancer: an EPIC-based real-world comparative study.
Jpn J Clin Oncol
Shirafuji T, Yamada Y, Saito M, Amemiya Y, Horikoshi T, Kubota Y, Sato K, Tamura T, Kurozumi A, Saito S, Ando K, Sazuka T, Imamura Y, Uno T, Sakamoto S.
PMID: 43038029 [PubMed - as supplied by publisher]
Study Rationale, Enrollment Characteristics, and Central Review of Clinical Stage: The INTACT Randomized Clinical Trial.
JAMA Netw Open
Singh P, Plets M, Efsthathiou J, Jhavar SG, Tangen C, Delacroix S Jr, Marquette C, Mouw KW, Khalil MF, Ballas LK, Sachdev S, Johnson BA 3rd, Jani A, Cross B, Grivas P, Palopoli J, Kirchner A, Shen X, Parikh M, Olson A, Mehan P, Costello B, Joshi M, Daneshmand S, Petrylak D, Thompson I, Nguyen PL, Lerner SP.
PMID: 43037986 [PubMed - indexed for MEDLINE]
Evaluating Artificial Intelligence Chatbots for Patient Education on Prostate Biopsy in the Prostate Cancer Diagnostic Pathway.
J Cancer Educ
Olgun A, Zengin S.
PMID: 43037951 [PubMed - as supplied by publisher]
Biopsy-to-radical Prostatectomy ISUP Grade Discordance and Prostate Cancer-Specific Mortality: A Population-based SEER Study.
Ann Surg Oncol
Shan J, Liu Z, Zhang Q, Shi H, Ma L.
PMID: 43037853 [PubMed - as supplied by publisher]
The CALLY Index as an Independent Predictor of Survival in Bladder Cancer Patients Undergoing Radical Cystectomy: A Multicenter Study.
Urol Int
Topçu I, Ozdes AA, Dural B, Yildirim OF, Karakeci A, Çiçek R, Orhan I.
PMID: 43037501 [PubMed - as supplied by publisher]
Evaluating trends in treatment and outcomes of stage I renal cell carcinoma with machine learning: The RECLAIM-L (REnal cancer landscape and artificial intelligence with machine learning) database.
Ther Adv Urol
Fong KY, Gan VHL, Jonathan Aslim E, Tay KJ, Chen K, Tan YG, Yuanming Lee A, Yin Ting Loh J, Chew SX, Wai Sam Cheng C, Shyi Peng Yuen J, Sun Sien Ho H, Jean Lim E.
PMID: 43036519 [PubMed]
Machine learning-based prediction of BCG NON-RESPONSE in high-risk NON-muscle-invasive bladder cancer: An exploratory single-centre cohort study.
Ther Adv Urol
, Sevim M, Körpe K, At, Arslan V, Görür S, Gökalp F.
PMID: 43036513 [PubMed]
Circulating tumor DNA as a tool for precision management in bladder cancer: A narrative review.
Ther Adv Urol
Manivasagam SS, Sheikhsaran F, Raman JD, Aminsharifi A.
PMID: 43036426 [PubMed]
A Case of Wilms Tumor in a Patient With Beckwith-Wiedemann Syndrome: Clinical Presentation and Management.
Cancer Rep (Hoboken)
Benlhachemi S, Khattab M, Alhamany Z, Abouqal R, El Fahime E.
PMID: 43036296 [PubMed - indexed for MEDLINE]
Men's health awareness in focus: knowledge of testicular cancer and awareness of testicular self-examination practices among men in Saudi Arabia.
BMC Public Health
Alsharif F, Gusti SA, Qurban A, Alomary S, Zainalabdeen A, Alsiary R.
PMID: 43035751 [PubMed - indexed for MEDLINE]
Association between puberty timing and overall survival in male cancer patients: a prospective cohort analysis from the UK Biobank.
BMC Cancer
Zhang Q, Xu J, Deng S, Li X, Li Z, Xing S, Wang S, Ma H.
PMID: 43035660 [PubMed - indexed for MEDLINE]
Prognostic value of ctDNA in patients with prostate cancer: a meta-analysis and trial sequential analysis.
BMC Cancer
Hao X, Xiao H, Li M, Wu J, Niu S, Xiong T, Wang P, Liu X.
PMID: 43035452 [PubMed - indexed for MEDLINE]
Adding Immune Checkpoint Inhibitors to Bladder-Preservation Therapy in Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis.
Crit Rev Oncol Hematol
Ghalehtaki R, Shariati A, Mehrtabar E, Arshadi MR, Fanihagh T.
PMID: 43035127 [PubMed - as supplied by publisher]
Articles 1 - 20 / 183006
Page 1 of 9151
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy